RhumbLine Advisers
SNY icon

RhumbLine Advisers’s Sanofi SNY Stock Holding History

RhumbLine Advisers’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.87M Sell
43,933
-452
-1% -$20.2K ﹤0.01% 1972
2026
Q1 		$2.14M Buy
44,385
+229
+0.5% +$10.7K ﹤0.01% 1818
2025
Q4 		$2.14M Sell
44,156
-1,073
-2% -$53.2K ﹤0.01% 1846
2025
Q3 		$2.13M Sell
45,229
-1,541
-3% -$74.4K ﹤0.01% 1873
2025
Q2 		$2.26M Buy
46,770
+1,016
+2% +$51.9K ﹤0.01% 1821
2025
Q1 		$2.54M Buy
45,754
+5,477
+14% +$296K ﹤0.01% 1697
2024
Q4 		$1.94M Sell
40,277
-4,491
-10% -$228K ﹤0.01% 1893
2024
Q3 		$2.58M Buy
44,768
+1,980
+5% +$107K ﹤0.01% 1762
2024
Q2 		$2.08M Buy
42,788
+911
+2% +$43.9K ﹤0.01% 1861
2024
Q1 		$2.04M Buy
41,877
+2,926
+8% +$143K ﹤0.01% 1908
2023
Q4 		$1.94M Sell
38,951
-127
-0.3% -$6.21K ﹤0.01% 1919
2023
Q3 		$2.1M Buy
39,078
+5,370
+16% +$286K ﹤0.01% 1833
2023
Q2 		$1.82M Buy
+33,708
New +$1.81M ﹤0.01% 1962
2021
Q1 		– Sell
-4,519
Closed -$220K – 3025
2020
Q4 		$220K Buy
+4,519
New +$223K ﹤0.01% 2800
2016
Q3 		– Sell
-26,510
Closed -$1.11M – 2930
2016
Q2 		$1.11M Hold
26,510
– – ﹤0.01% 1722
2016
Q1 		$1.06M Hold
26,510
– – ﹤0.01% 1748
2015
Q4 		$1.13M Buy
26,510
+1,800
+7% +$82.8K ﹤0.01% 1730
2015
Q3 		$1.17M Hold
24,710
– – ﹤0.01% 1667
2015
Q2 		$1.22M Sell
24,710
-8,200
-25% -$416K ﹤0.01% 1734
2015
Q1 		$1.63M Sell
32,910
-1,000
-3% -$47.8K ﹤0.01% 1534
2014
Q4 		$1.55M Hold
33,910
– – ﹤0.01% 1530
2014
Q3 		$1.91M Hold
33,910
– – 0.01% 1345
2014
Q2 		$1.8M Hold
33,910
– – 0.01% 1451
2014
Q1 		$1.77M Sell
33,910
-200
-0.6% -$10.1K 0.01% 1425
2013
Q4 		$1.83M Buy
34,110
+18,200
+114% +$939K 0.01% 1430
2013
Q3 		$806K Buy
15,910
+6,300
+66% +$321K ﹤0.01% 1915
2013
Q2 		$495K Buy
+9,610
New +$512K ﹤0.01% 2264

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

RhumbLine Advisers's SNY Position: Q2 2026 in Review

RhumbLine Advisers reduced its Sanofi (SNY) stake by 1% in Q2 2026, selling an estimated $20.2K and leaving 43,933 shares worth $1.87M. The position accounts for ﹤0.01% of the portfolio, ranked #1972.

RhumbLine Advisers first reported a position in SNY in Q2 2013 and has held it in 27 quarters since. The position peaked at $2.58M in Q3 2024. 718 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • RhumbLine Advisers held 43,933 shares of Sanofi worth $1.87M as of Q2 2026.
  • RhumbLine Advisers sold 452 Sanofi shares in Q2 2026, an estimated $20.2K.
  • Sanofi made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #1972 holding.
  • RhumbLine Advisers first reported a position in Sanofi in Q2 2013 and has held it in 27 quarters since.
  • RhumbLine Advisers's Sanofi position peaked at $2.58M in Q3 2024.
  • 718 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.